Sign inJoin waitlistJoin the waitlist

Qaiser Bashir

Fellowship Program Director · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · ·

History

University of Texas M D Anderson Cancer Center Fellowship
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Duke Fuqua School of Business
2023
University of Texas M D Anderson Cancer Center
2009–2010
Hematology and Medical Oncology
University of Colorado School of Medicine
2006–2009
Internal Medicine
University of Missouri-Columbia School of Medicine
2003–2004
King Edward Medical University
2001

Research

Cardiotoxicity of cancer therapy
Review · Journal of Clinical Oncology · 2005 · 251 citations
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation
Biology of Blood and Marrow Transplantation · 2012 · 202 citations
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and…
Biology of Blood and Marrow Transplantation · 2014 · 182 citations

Richard Champlin
162 papers
Muzaffar Qazilbash
150 papers
Uday Popat
116 papers
Partow Kebriaei
112 papers
Elizabeth Shpall
111 papers
Yago Nieto
106 papers
Chitra Hosing
98 papers
Robert Orlowski
80 papers
Samer Srour
78 papers · 3 as a fellow
Krina Patel
65 papers
Amin Alousi
64 papers
Sheeba Thomas
61 papers

Clinical trials

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2024–2031
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2022–2027
Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2020–2023
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation
Principal investigator · Completed · Phase 1, Phase 2
M.D. Anderson Cancer Center
2019–2024